Bentley-based biotech company Recce has popped the cork on its first day of trading on the ASX, following completion of a $5 million initial public offering.
A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.